Biliana Veleva-Rotse

Years Active: 2019-2023
Publications (10 Years): 2

Amicus Therapeutics Inc

Oregon Health and Science University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Amicus Therapeutics Inc

United States

Medical Science Liaison Associate Director :: Medical Affairs

Novartis Pharmaceuticals Corp Jul 11 2016 - Apr 15 2018

United States

Medical Science Liaison Manager :: Medical Affairs

Oregon Health and Science University Jan 26 2015

United States

Postdoctoral Researcher :: Neurology

Education History

Oregon Health and Science University

United States

PHD :: Pediatrics

Publications

Ian Keyzor, Simon Shohet, Jeff Castelli, Sheela Sitaraman, Biliana Veleva-Rotse, Jill M Weimer, Brian Fox, Tobias Willer, Steve Tuske, Louise Crathorne, Klara J Belzar
Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification. Biomolecules 13 (8) (2023)
Sarah J Garnai, Michelle L Brinkmeier, Ben Emery, Tomas S Aleman, Louise C Pyle, Biliana Veleva-Rotse, Robert A Sisk, Frank W Rozsa, Ayse Bilge Ozel, Jun Z Li, Sayoko E Moroi, Steven M Archer, Cheng-Mao Lin, Sarah Sheskey, Laurel Wiinikka-Buesser, James Eadie, Jill E Urquhart, Graeme C M Black, Mohammad I Othman, Michael Boehnke, Scot A Sullivan, Gregory L Skuta, Hemant S Pawar, Alexander E Katz, Laryssa A Huryn, Robert B Hufnagel, null null, Sally Ann Camper, Julia E Richards, Lev Prasov
Variants in myelin regulatory factor (MYRF) cause autosomal dominant and syndromic nanophthalmos in humans and retinal degeneration in mice. PLoS genetics 15 (5) (2019)

Biliana Veleva-Rotse.css-eqlu8i{font-size:small;padding-left:4px;}